Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $283.55 million. The enterprise value is $75.67 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 74.23 million shares outstanding. The number of shares has increased by 109.82% in one year.
| Current Share Class | 74.23M |
| Shares Outstanding | 74.23M |
| Shares Change (YoY) | +109.82% |
| Shares Change (QoQ) | +2.17% |
| Owned by Insiders (%) | 4.86% |
| Owned by Institutions (%) | 62.15% |
| Float | 58.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 182.14 |
| Forward PS | n/a |
| PB Ratio | 0.99 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 51.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.02, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.02 |
| Quick Ratio | 16.70 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -514.45 |
Financial Efficiency
Return on equity (ROE) is -32.92% and return on invested capital (ROIC) is -18.14%.
| Return on Equity (ROE) | -32.92% |
| Return on Assets (ROA) | -15.56% |
| Return on Invested Capital (ROIC) | -18.14% |
| Return on Capital Employed (ROCE) | -23.88% |
| Revenue Per Employee | $10,507 |
| Profits Per Employee | -$608,371 |
| Employee Count | 140 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.14% in the last 52 weeks. The beta is 1.12, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -62.14% |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | 5.51 |
| Relative Strength Index (RSI) | 64.17 |
| Average Volume (20 Days) | 1,621,269 |
Short Selling Information
The latest short interest is 5.28 million, so 7.11% of the outstanding shares have been sold short.
| Short Interest | 5.28M |
| Short Previous Month | 5.27M |
| Short % of Shares Out | 7.11% |
| Short % of Float | 8.95% |
| Short Ratio (days to cover) | 7.40 |
Income Statement
In the last 12 months, CATX had revenue of $1.47 million and -$85.17 million in losses. Loss per share was -$1.21.
| Revenue | 1.47M |
| Gross Profit | -44.20M |
| Operating Income | -75.62M |
| Pretax Income | -50.57M |
| Net Income | -85.17M |
| EBITDA | -72.95M |
| EBIT | -75.62M |
| Loss Per Share | -$1.21 |
Full Income StatementBalance Sheet
The company has $211.70 million in cash and $3.82 million in debt, giving a net cash position of $207.88 million or $2.80 per share.
| Cash & Cash Equivalents | 211.70M |
| Total Debt | 3.82M |
| Net Cash | 207.88M |
| Net Cash Per Share | $2.80 |
| Equity (Book Value) | 284.65M |
| Book Value Per Share | 3.84 |
| Working Capital | 203.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.72 million and capital expenditures -$50.00 million, giving a free cash flow of -$103.72 million.
| Operating Cash Flow | -53.72M |
| Capital Expenditures | -50.00M |
| Free Cash Flow | -103.72M |
| FCF Per Share | -$1.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -5,140.99% |
| Pretax Margin | -5,899.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -109.82% |
| Shareholder Yield | -109.82% |
| Earnings Yield | -30.04% |
| FCF Yield | -36.58% |
Analyst Forecast
The average price target for CATX is $12.90, which is 237.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.90 |
| Price Target Difference | 237.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 174.97% |
| EPS Growth Forecast (5Y) | -0.27% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
CATX has an Altman Z-Score of 7.55 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.55 |
| Piotroski F-Score | 3 |
